Leading brokers name 3 ASX shares to buy today

Here's why brokers rate these ASX shares as buys…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Business man marking buy on board and underlining it.

Image Source: Getty Images

Iluka Resources Limited (ASX: ILU)

According to a note out of Credit Suisse, its analysts have upgraded this mineral sands and rare earths miner's shares to an outperform rating with a $10.00 price target. This broker was pleased enough with Iluka's quarterly production and the strong prices it received. And while Credit Suisse has some small doubts over its production guidance, it isn't enough to stop it from upgrading its shares. Particularly given its catalyst-rich schedule which it feels could drive its shares higher. The Iluka share price is trading at $8.68 on Monday.

Macquarie Group Ltd (ASX: MQG)

A note out of Morgans reveals that its analysts have retained their add rating on this investment bank's shares with a trimmed price target of $214.30. This follows the release of a first half result which revealed a stronger than expected profit. Overall, Morgans highlights that Macquarie is a quality franchise, well exposed to structural growth areas, and is managing a more difficult FY 2023 environment well. The Macquarie share price is fetching $169.15.

ResMed Inc. (ASX: RMD)

Another note out of Morgans reveals that its analysts have retained their add rating on this sleep treatment company's shares with a slightly lower price target of $37.00. Morgans was pleased with ResMed's quarterly update, highlighting that its first quarter result was better than expected. So, with supply chain pressures easing, the broker believes that ResMed's outlook is very positive. The ResMed share price is trading at $33.98 on Monday afternoon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool Australia has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Couple on their laptop in their home kitchen.
Broker Notes

Buy, hold, sell: Challenger, APA Group, Mesoblast shares

Experts reveal their insights on these stocks in the finance, utilities, and healthcare sectors.

Read more »

A woman wearing a flowing red dress, poses dramatically on a beach with the sea in the background.
Broker Notes

3 ASX shares tipped by broker to rise 70% to 120%

Morgans predicts these ASX shares will rip over the next 12 months.

Read more »

A middle-aged lady screws her face up into a wince as though imaging an uncomfortable or awkward scenario.
Broker Notes

5 ASX shares downgraded by Morgans post-results

But that doesn't mean sell!

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

2 ASX fintechs to buy for 60% to 70% returns

These junior financial companies could deliver significant upside.

Read more »

A woman has a quizzical look on her face as though she is deciding something in the foreground of a backdrop featuring five stars, like the Australian five star energy rating system.
Broker Notes

Buy, hold, sell: Mineral Resources, Ansell, CBA shares

Let's check out some new ratings for these ASX 200 shares.

Read more »

Two work colleagues looking at a laptop and discussing something.
Broker Notes

Buy, hold, sell: Boss Energy, Magellan, and NextDC shares

Morgans has given its verdict on these shares following earnings season.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Broker Notes

Up 75%! Why this rocketing ASX All Ords stock is forecast to deliver more outsized gains

A top broker forecasts more outperformance from this soaring ASX stock. But why?

Read more »

Hand stacking increasing piles of rocks.
Broker Notes

5 ASX 200 shares with 33% to 61% upside post-results: experts

As earnings season comes to a close, here are the new 12-month price targets from the experts.

Read more »